Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease.
Gouilly D, Vrillon A, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Nogueira L, Mouton-Liger F, Planton M, Salabert AS, Hitzel A, Méligne D, Jasse L, Sarton B, Silva S, Lemesle B, Péran P, Payoux P, Thalamas C, Paquet C, Pariente J.
Gouilly D, et al. Among authors: payoux p.
Neuroimage Clin. 2024;43:103626. doi: 10.1016/j.nicl.2024.103626. Epub 2024 May 31.
Neuroimage Clin. 2024.
PMID: 38850834
Free PMC article.